Shorts Set $1.00 Price Target on Inovio (INO) $9.20.
Interesting battle brewing!
LIVE CHART
Inovio shares tumble 8%...
Aphex BioCleanse Hand Sanitizer Seeking FDA GRAS Approval.
Aphex BioCleanse Systems Enters Agreement with Now Biopharma for Hand Sanitizer Clinical Trial
PITTSFORD, N.Y., Aug. 31, 2020 /PRNewswire/ -- Aphex...
Look What We Found. A Bavarian Cure for the Common Cold and CoronaVirus Play!
Adding Bavarian Nordic (BVNRY) $10.50 Adding to CoronaVirus Watch List.
Wait Until Robinhood Traders Find Out...
Photos: Aphex BioCleanse Systems.
We had the opportunity to visit the Aphex BioCleanse Systems manufacturing facility on 8-18-2020. Truly impressive seeing tanks readying for shipment, and...
Clorox and P&G Struggle to Meet COVID-19-Related Spike in Demand (MarketWatch).
Clorox shares have soared more than 54% for the year to date, an increase of $11.5 billion to $29.5 billion.
Does Co-Diagnostics (CODX) Have Ties to Offshore Boiler Rooms?
Hot Covid-19 test company has ties to offshore boiler rooms (SharesSleuth.com)
AKA, you'd have to have your head examined...
Investors Bet $8 Million on Citius Pharma (CTXR) $1.10, Succeeding in FDA Trials!
Great headline, right?
The actual headline was: Citius Pharmaceuticals Increases Previously Announced Bought Deal Offering to $8.4 Million
Our Favorite Hand Sanitizer Company, Aphex BioCleanse Systems Inc., is Now Publicly Traded!
Sunset Capital Assets, Inc., (SNST), Executes and Completes Definitive Share Exchange Agreement with Aphex BioCleanse Systems Inc.
Our favorite...
2020 Biotech Portfolio Soars 55%, We’re Amazed. Next Up: The Coming Gold Rush.
1. Yep, We Are Absolutely Amazed At The Biotech Stock Review's 2020 Watch List Performance – Especially In The Light Of...
Latest article
Institutional Analyst Newsletter. Citius (CTXR), GeoVax (GOVX.
DERBY WEEKEND - WE'RE HEADED TO TAMPA!HAT'S ON, DRINK'S UPADDING CITIUS PHARMA (CTXR) $0.66, TO WATCHLISTUPDATING GEOVAX LABS (GOVX) $1.43OUR $26...
Adding Citius Pharma (CTXR) $0.66 to 2024 Watch List.
Three Years Since we Last Added Citius (CTXR) to the Watch List, and it Looks Better Than Ever!
Citius Pharmaceuticals (CTXR) Prospectus, Powerpoint & Fact Sheet.
CRANFORD, N.J., April 26, 2024 /PRNewswire/ -- Citius Pharmaceuticals Inc. (Nasdaq: CTXR) ("Citius" or the "Company"), a late-stage biopharmaceutical company dedicated to the development and commercialization...
